U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List).
出版信息
Int J Pharm Compd. 2016 Nov-Dec;20(6):457-458.
PMID:28339383
Abstract
摘要
相似文献
1
U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List).
Int J Pharm Compd. 2016 Nov-Dec;20(6):457-458.
2
The "Lists": What Do They Mean?
Int J Pharm Compd. 2016 Nov-Dec;20(6):477-479.
3
Introduction to Quality Control in a Compounding Pharmacy.
Int J Pharm Compd. 2016 Nov-Dec;20(6):481-484.
4
2013 State Compounding Legislation Tracker.
Int J Pharm Compd. 2013 Sep-Oct;17(5):375-8.
5
Compounding pharmacies: before and after an inspection.
Int J Pharm Compd. 2013 Sep-Oct;17(5):358-62.
6
Compounding interest: a tragedy caused by contaminated steroids turned the spotlight on compounding pharmacies.
State Legis. 2013 Jun;39(6):22-3.
7
FDA, states discuss pharmacy compounding regulatory framework.
Am J Health Syst Pharm. 2013 Feb 1;70(3):180, 182. doi: 10.2146/news130010.
8
Improving and enforcing compounding pharmacy practices to protect patients.
Clin Infect Dis. 2006 Oct 1;43(7):838-40. doi: 10.1086/507341. Epub 2006 Aug 22.
9
Analytic Methods Used in Quality Control in a Compounding Pharmacy.
Int J Pharm Compd. 2017 Jan-Feb;21(1):31-37.
10
U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies.
Int J Pharm Compd. 2017 Mar-Apr;21(2):95-102.
Zotero 插件